Literature DB >> 27478455

Cognitive variations among vascular dementia subtypes caused by small-, large-, or mixed-vessel disease.

Huang Ying1, Chen Jianping1, Yuan Jianqing1, Zhong Shanquan1.   

Abstract

INTRODUCTION: Vascular dementia (VaD) is a heterogeneous disease that can vary in clinical presentation and cognitive profile. The cognitive profiles of different VaD subtypes depend on the anatomical distribution of the vascular insults that have been documented.
MATERIAL AND METHODS: We reviewed demographic, cognitive, and imaging data in 402 patients who were clinically diagnosed with VaD between January 2002 and June 2012 at the First Affiliated Hospital of Gan Nan Medical College in Ganzhou, China.
RESULTS: Based on magnetic resonance imaging (MRI) results, patients were classified as having large- (24.1%), small- (70.4%), or mixed-vessel VaD (5.5%). Hypertension was the most prevalent risk factor (81%), followed by smoking (37%), hyperlipidemia (35%), and diabetes (27%). Hyperlipidemia, cardiac risk factors (history of cardiovascular disease, heart valve disorder) and carotid stenosis were more frequent in patients with large-vessel disease compared to those with small-vessel or mixed-vessel disease (p < 0.001). A median of 4 (maximum 11) cognitive domains were impaired in each VaD patient. After memory dysfunction, executive defects were the most prevalent (68.9%), and neurobehavioral dysfunction was the most rare (13.2%). Patients with small-vessel VaD showed more executive dysfunction than patients with large-vessel and mixed-vessel VaD (p < 0.05), whereas patients with large-vessel VaD had a higher prevalence of visuospatial or language dysfunction (p < 0.05).
CONCLUSIONS: The results indicate that specific subtypes and underlying vascular mechanisms will help predict clinical courses and produce more focused treatment and prevention of VaD.

Entities:  

Keywords:  cognition; domain; vascular dementia

Year:  2016        PMID: 27478455      PMCID: PMC4947622          DOI: 10.5114/aoms.2016.60962

Source DB:  PubMed          Journal:  Arch Med Sci        ISSN: 1734-1922            Impact factor:   3.318


Introduction

Vascular dementia (VaD) is a common type of dementia that is affecting a growing number of elderly individuals worldwide [1, 2]. It is the second leading cause of dementia among the elderly in China; VaD is responsible for more than 25% of all the dementia cases and is only surpassed in prevalence by Alzheimer's disease (AD) [3, 4]. Vascular dementia is a heterogeneous disease that can vary in clinical presentation and cognitive profile. VaD can be caused by small-vessel disease (characterized by lacunes, white matter hyperintensities, or bilateral thalamic lesions), large-vessel disease (large territorial or strategic infarcts) [5, 6], or mixed-vessel disease. The cognitive profiles of different VaD subtypes depend on the anatomical distribution of the vascular insults. For example, executive dysfunction and mild memory deficits were proposed as the major part of subcortical ischemic VaD [7]. Previous studies reported that subcortical vascular disease was associated with deficits in working memory, visuomotor speed, and executive dysfunction [8]. Therefore, we hypothesized that VaD patient cognitive profiles offer clues to the type of underlying vascular disease and thus may be a useful diagnostic tool. The aims of this study were to characterize cognitive function profiles with respect to domain dysfunction in different subtypes of VaD patients using neuropsychological tests and assessing magnetic resonance imaging (MRI) using well-defined radiological criteria [6].

Material and methods

We analyzed the medical records of 402 patients who were diagnosed with VaD between January 2002 and June 2012 in our hospital. The patients were eligible for inclusion according to the following criteria: age ≥ 40 years; fulfillment of the NINDS-AIREN criteria for probable VaD [9]; MRI evidence of ischemic cerebrovascular disease, including ischemic stroke or white matter lesions; a Mini-Mental State Examination (MMSE) score of 10–26 [10]; and a score of 4 or more on the modified Hachinski Ischemia Scale (HIS) [11]. Patients diagnosed with any primary neurodegenerative disorders, space-occupying lesions, or lobar hemorrhages were excluded, as were patients without complete clinical evaluation and brain imaging. This retrospective study protocol was approved by the Clinical Research Ethics Committee of our hospital. We collected the following data for each patient: demographic variables, including age, sex, and education; risk factors for dementia, including hypertension, diabetes mellitus, hyperlipidemia, cerebrovascular disease, cardiovascular disease, heart valve disorder, carotid stenosis, or peripheral vascular disease. Patients were also asked if they had a history of smoking. All patients had undergone MRI. All patients were initially evaluated with the MMSE [10], followed by assessments of neurobehavioral function, memory, executive function, orientation, attention, abstract thinking, calculation, language function, mental control, praxis-gnosis, and visuospatial function. Attention and abstract thinking were respectively evaluated by the Digit Span Forward test and picture completion from Choynowski's Memory Scale [12]. Calculation, orientation, and visuospatial function were assessed by the arithmetic, spatial and temporal, and crossing-pentagons items from the MMSE, respectively [10]. Cortical functional domains were assessed with selected cognitive tests. Language fluency was tested by category naming of animals in 1 min [13], and praxis-gnosis was estimated with Western Aphasia Battery ideomotor apraxia subtest items [14]. Memory was assessed by the Wechsler Memory Scale (WMS) [15], and mental control and executive functions were evaluated with the revised Wechsler Memory Scale (WMS-R) [16] and trail-making test B (TMT-B), respectively [17]. Neurobehavioral function was evaluated with the caregiver-based 12-item Neuropsychiatric Inventory (NPI) [18]. The specific neuropsychological battery included the HIS [11]. Vascular abnormality assessment included the items of the radiological NINDS-AIREN criteria for VaD according to previously proposed operational definitions [5]. Magnetic resonance imaging (MRI) assessment was performed using well-defined radiological diagnosis by Jellinger in 2008 [6]. Based on these criteria, patients were classified as having large-vessel VaD (strategic large-vessel infarct of the dominant hemisphere or bilateral hemispheric strokes), small-vessel VaD (white-matter hyperintensities involving ≥ 25% of white matter, multiple lacunes, or bilateral thalamic lesions) or mixed-vessel VaD. Magnetic resonance imaging was performed on a 1.5-Tesla machine (Magnetom Impact Expert Siemens AG, Erlangen, Germany) following a standard protocol, including coronal T1-weighted 3D magnetization-prepared rapid acquisition with gradient echo (MPRAGE), axial fluid-attenuated inversion recovery (FLAIR), and axial spin-echo T2-weighted images.

Statistical analysis

All statistical analyses were performed using the SPSS computerized statistics package (version 17.0; Chicago, IL, USA). Baseline demographics were analyzed using descriptive statistics. Differences in baseline characteristics and risk factors among the different types of VaD groups (small-vessel VaD, large-vessel VaD or mixed small/large-vessel VaD) were analyzed using the χ2 test for dichotomous outcome variables and one-way analysis of variance (ANOVA), and Newman-Keuls tests (NK) were applied to continuous data. The χ2 tests were subsequently used to compare impaired cognitive domains among the different VaD groups. The results of statistical tests were considered significant at the level of p < 0.05.

Results

Patient demographics and risk factors are shown in Table I. The total study population included 402 VaD patients (mean age: 69 years), and the mean MMSE score of the patients was 16. Based on the operational definitions for the radiological component of the NINDS-AIREN criteria, 283 (70.4%) patients had small-vessel VaD, 97 (24.1%) had large-vessel VaD, and 22 (5.5%) had mixed-vessel VaD. Patients with large-vessel VaD were older compared with patients with small-vessel VaD (p < 0.05). MMSE scores were comparable among the three groups. Overall, hypertension was the most prevalent risk factor (81%), followed by smoking (37%), hyperlipidemia (35%), and diabetes (27%). Hyperlipidemia, cardiac risk factors (history of cardiovascular disease, heart valve disorder) and carotid stenosis were more frequent in patients with large-vessel disease compared to those with small-vessel or mixed-vessel disease (p < 0.001); but smoking, peripheral vascular disorder and diabetes were equally distributed among the different VaD subtypes.
Table I

Demographics and risk factors of VaD subtypes

ParameterSmall-vessel VaDLarge-vessel VaDMixed-vessel VaDχ2 or F-valueOverall unadjusted p-value
No. of patients (%)283 (70.4)97 (24.1)22 (5.5)
Age, mean ± SD [years]68.3 ±7.170.5 ±9.2[a]69.3 ±8.43.980.026
Female, n (%)92 (31.8)35 (36.1)11 (50.0)0.240.814
Male, n (%)191 (68.2)62 (63.9)11 (50.0)
Education, mean ± SD [years]9.6 ±3.58.2 ±2.19.3 ±2.22.230.133
MMSE, mean ± SD15.7 ±3.217.4 ±3.418.6 ±4.11.650.476
Hypertension, n (%)226 (79.9)81 (83.5)18 (81.8)0.130.963
Diabetes mellitus, n (%)71 (25.1)29 (29.9)7 (31.8)1.880.435
Hyperlipidemia, n (%)85 (30.0)[b,c]48 (49.5)9 (40.9)4.69< 0.001
Cardiovascular disease, n (%)36 (12.7)29 (29.9)[a,c]3 (13.6)5.27< 0.001
Heart valve disorder, n (%)39 (13.8)40 (41.2)[a,c]3 (13.6)8.33< 0.001
Carotid stenosis, n (%)23 (8.1)21 (22.7)[a,c]2 (9.1)6.48< 0.001
Peripheral vascular disease, n (%)17 (6.0)6 (6.2)2 (9.1)1.010.662
Smoking, n (%)110 (38.9)37 (38.1)9 (40.9)0.160.893

MMSE – Mini-Mental State Examination.

Significantly different compared to patients with small-vessel VaD

significantly different compared to patients with large-vessel VaD

significantly different compared to patients with mixed-vessel VaD.

Demographics and risk factors of VaD subtypes MMSE – Mini-Mental State Examination. Significantly different compared to patients with small-vessel VaD significantly different compared to patients with large-vessel VaD significantly different compared to patients with mixed-vessel VaD. The median was 4 impaired cognitive domains per patient (Figure 1). However, the number of impaired cognitive domains did not differ among VaD patient groups (p = 0.36). In all, we examined 11 cognitive domains (Figure 2). Besides memory defect, executive dysfunction was the most common (68.9%), followed by calculation defects (40.5%), language dysfunction (39.6%), and mental control dysfunction (33.8%). Neurobehavioral defects were the least common (13.2%). The relative prevalence of executive, visuospatial, and language dysfunction was significantly different among the different VaD subtypes (p < 0.001) (Table II). By using logistic regression models controlling for age, we found that executive dysfunction was more prevalent in patients with small-vessel VaD compared with patients with large-vessel and mixed-vessel VaD (p < 0.05). Notably, patients with large-vessel VaD more frequently exhibited visuospatial and language-verbal dysfunction (p < 0.05). Other cognitive domain impairments, including memory, orientation, calculation, abstract thinking, praxis-gnosis, mental control, and attention dysfunction were equally distributed among the three VaD patient subtypes.
Figure 1

Frequency distribution of the number of impaired cognitive domains per patient (n = 402)

Figure 2

Percentages of patients presenting individual cognitive domain impairment (n = 402)

Table II

Prevalence of cognitive domain impairment by VaD subtype

VariableSmall-vesselVaD(n = 283)Large-vesselVaD(n = 97)Mixed-vesselVaD(n = 22)Chi-square overallunadjustedP-value
Abstract thinking77 (27.2%)30 (30.9%)4 (18.2%)0.464
Attention88 (31.1%)35 (36.1%)6 (27.3%)0.480
Calculation116 (41.0%)43 (44.3%)4 (18.2%)0.334
Executive223 (78.8%)[b,c]38 (39.2%)16 (72.7%)< 0.001
Language94 (33.2%)57 (58.8%)[a]8 (36.4%)< 0.001
Mental control96 (33.9%)33 (34.0%)7 (31.8%)0.979
Neurobehavior35 (12.4%)16 (16.5%)2 (9.1%)0.493
Orientation70 (24.7%)19 (19.6%)8 (36.4%)0.229
Praxis-gnosis95 (33.6%)26 (26.8%)7 (31.8%)0.467
Visuospatial44 (15.5%)36 (37.1%)[a,c]9 (40.9%)< 0.001

Significantly different compared to patients with small-vessel VaD

significantly different compared to patients with large-vessel VaD

significantly different compared to patients with mixed-vessel VaD.

Frequency distribution of the number of impaired cognitive domains per patient (n = 402) Percentages of patients presenting individual cognitive domain impairment (n = 402) Prevalence of cognitive domain impairment by VaD subtype Significantly different compared to patients with small-vessel VaD significantly different compared to patients with large-vessel VaD significantly different compared to patients with mixed-vessel VaD.

Discussion

The main findings of the present study are that the domain profile of cognitive dysfunction differs among VaD subtypes, and that these subtypes are associated with specific risk factors. Specifically, we demonstrated that executive dysfunction is more prevalent in patients with small-vessel VaD compared with large- and mixed-vessel VaD, whereas language and visuospatial dysfunction were more often observed in patients with large-vessel VaD. As the biological dementia process begins years before it is diagnosed clinically, the preclinical period of the disease, when neuronal degeneration has begun, but cellular and biochemical damage is not yet sufficient for symptoms to manifest, is the optimal time to initiate a neuroprotective therapy [19]. Currently molecular imaging methods are state-of-the-art to diagnose dementia [20]. For example, MRI enabled the visualization of specific structures within the medial temporal lobe, such as the hippocampus itself, the parahippocampal gyrus, subiculum, entorhinal cortex, and amygdale, with good clinical correlations with dementia [21]. Resting-state functional magnetic resonance imaging detected that amplitude low-frequency fluctuations of the right angular gyrus in the slow-5 band are more specific for diagnosing subcortical ischemic vascular disease [22]. Hence, the differences in patterns of cognitive domain deficits between the subtypes in VaD could be explained by the heterogeneity with regard to the location of lesions. Medial temporal location is consistent with the characteristic amnestic state in large-vessel VaD [23], whereas basal ganglia infarcts usually produce executive dysfunction [24]. Alternatively, infarcts in the thalamus, which is an important area in the episodic memory circuit, could cause memory impairment in some subcortical VaD patients [23]. Executive dysfunction in VaD patients with extensive white matter hyperintensities may be explained by frontal hypometabolism, which was mostly characterized by weakened goal-directed actions [25]. Poor working memory and executive dysfunction in subcortical VaD may be the result of disrupted frontal-subcortical circuits [26]. The difference between VaD subtype cognitive profiles may be explained, on one hand, by the anatomical distribution of the vascular insults. For example, Alladi et al. [27] reported that small artery disease was more often associated with subcortical VaD than with cortical and cortical-subcortical VaD. It has been suggested that subcortical VaD is homogeneous, with small-vessel disease as the primary vascular etiology, lacunar infarcts and ischemic white matter lesions as the primary type of brain lesions, and subcortical clinical syndrome as the primary clinical manifestation. Consistent with our results, previous studies reported that subcortical VaD was associated with working memory deficits, visuomotor speed and executive dysfunction [28]. The VaD patients with extensive white matter hyperintensities or multiple lacunar infarctions also showed executive dysfunction [29]. On the other hand, neurotransmitters have been reported to be decreased in dementia patients, especially in the case of acetylcholine, which is a potent vasodilator innervating local cortical nitroxidergic interneurons, cerebral capillaries and microarterioles. A clinical study also found that acetylcholine esterase inhibitor increased the basal cerebral blood flow and could be used to treat dementia [30]. So, the nonuniform cholinergic cortical innervation could explain the regional profile variability in dementia patients. At the same time, our study examined the relative proportion of small-vessel disease of VaD in the southern Chinese Jiangxi Province, which has a population of 900 million people, an area of 39,400 square kilometers and a subtropical humid monsoon climate. Similar to our results, a cross-sectional community-based study of 706 VaD patients reported relative prevalences of 74%, 18%, and 8% for small-, large-, and mixed-vessel disease, respectively [31]. A previous neuropathological study provided support for the view that small-vessel disease is the main component of VaD [32]. Given that this is a retrospective study, there is a lack of data to evaluate cognitive dysfunction severity, and there is also a selection bias. In addition, due to the lack of integrated data, the effects of physical disabilities on cognition among vascular dementia subtypes were not determined. Therefore, further prospective clinical research is needed, particularly in order to evaluate the severity of cognitive dysfunction and the effects of physical disabilities on cognition by MRI and neuropsychological examinations in VaD. Future studies are also required to predict the course of disease by specifying the subtypes and underlying vascular mechanisms using MRI and develop cutting edge tools and concepts for constructing a VaD model, like that of Sun et al. [33] (Table III).
Table III

Performance of magnetic resonance imaging in subtypes of vascular dementia (VaD)

Subtypes of VaDMR imagingInformation
Small-vessel VaDMultiple lacunar cerebral infarction in basal ganglia in T2 imaging
Large-vessel VaDRight side of the temporal and parietal infarction in T2 imaging
Mixed-vessel VaDRight side of basal ganglia region infarction with cerebral white matter lesions by ventricle in FLAIR imaging
Performance of magnetic resonance imaging in subtypes of vascular dementia (VaD)
  27 in total

Review 1.  Episodic memory, amnesia, and the hippocampal-anterior thalamic axis.

Authors:  J P Aggleton; M W Brown
Journal:  Behav Brain Sci       Date:  1999-06       Impact factor: 12.579

2.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Authors:  K A Welsh; N Butters; R C Mohs; D Beekly; S Edland; G Fillenbaum; A Heyman
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

3.  Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu.

Authors:  Zhen-Xin Zhang; Gwendolyn E P Zahner; Gustavo C Román; Jun Liu; Zhen Hong; Qiu-Ming Qu; Xie-He Liu; Xiao-Jun Zhang; Bing Zhou; Cheng-Bing Wu; Mao-Ni Tang; Xia Hong; Hui Li
Journal:  Arch Neurol       Date:  2005-03

Review 4.  Morphologic diagnosis of "vascular dementia" - a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neurol Sci       Date:  2008-05-02       Impact factor: 3.181

5.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

6.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

Review 7.  The prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies.

Authors:  Meng-jie Dong; Bin Peng; Xiang-tong Lin; Jun Zhao; Yan-rong Zhou; Run-hua Wang
Journal:  Age Ageing       Date:  2007-10-25       Impact factor: 10.668

8.  Pathological verification of ischemic score in differentiation of dementias.

Authors:  W G Rosen; R D Terry; P A Fuld; R Katzman; A Peck
Journal:  Ann Neurol       Date:  1980-05       Impact factor: 10.422

Review 9.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

10.  Improved methodology to obtain large quantities of correctly folded recombinant N-terminal extracellular domain of the human muscle acetylcholine receptor for inducing experimental autoimmune myasthenia gravis in rats.

Authors:  Chenjing Sun; Hongliang Zhang; Jiang Xu; Jie Gao; Xiaokun Qi; Zhuyi Li
Journal:  Arch Med Sci       Date:  2013-08-12       Impact factor: 3.318

View more
  9 in total

Review 1.  Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.

Authors:  Keenan A Walker; Melinda C Power; Rebecca F Gottesman
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

2.  Pattern of cognitive deficits in vascular dementia.

Authors:  Prasenjit Sengupta; Jacky Ganguly; Sandip Pal; Malay Ghosal
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

Review 3.  Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit.

Authors:  Paola Caruso; Riccardo Signori; Rita Moretti
Journal:  Vasc Health Risk Manag       Date:  2019-08-07

4.  Effect of interactions between APOE and ESR1 polymorphisms on cognitive functions in postmenopausal women.

Authors:  Jarosław Pinkas; Iwona Bojar; Mariusz Gujski; Beata Sarecka-Hujar; Alfred Owoc; Dorota Raczkiewicz
Journal:  Arch Med Sci       Date:  2018-12-31       Impact factor: 3.318

5.  Cognitive Profile of Large-Vessel Vascular Dementia-An Observational Study from a Tertiary Care Center in Kolkata.

Authors:  Ashwani Bhat; Atanu Biswas
Journal:  J Neurosci Rural Pract       Date:  2022-05-13

6.  Frailty Is Associated With Cognitive Decline Independent of Cerebral Small Vessel Disease and Brain Atrophy.

Authors:  Timothy P Siejka; Velandai K Srikanth; Ruth E Hubbard; Chris Moran; Richard Beare; Amanda G Wood; Taya A Collyer; Siddhanth Gujjari; Thanh G Phan; Michele L Callisaya
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-09-01       Impact factor: 6.591

Review 7.  Heat therapy: possible benefits for cognitive function and the aging brain.

Authors:  Alex T Von Schulze; Fengyan Deng; Jill K Morris; Paige C Geiger
Journal:  J Appl Physiol (1985)       Date:  2020-09-24

8.  Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia.

Authors:  Mariola Bidzan; Leszek Bidzan; Ilona Bidzan-Bluma
Journal:  Arch Med Sci       Date:  2017-07-17       Impact factor: 3.318

9.  Lower retinal capillary density in minimal cognitive impairment among older Latinx adults.

Authors:  Bright S Ashimatey; Lina M D'Orazio; Samantha J Ma; Kay Jann; Xuejuan Jiang; Hanzhang Lu; Danny J J Wang; John M Ringman; Amir H Kashani
Journal:  Alzheimers Dement (Amst)       Date:  2020-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.